Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Fibrosis in systemic sclerosis.

John A Varga¹, Maria Trojanowska

¹Division of Rheumatology, Northwestern University Feinberg School of Medicine, McGaw 2300, 240 East Huron Street, Chicago IL 60611-2909, USA. j-varga@northwestern.edu

Rheumatic Diseases Clinics of North America

|March 11, 2008

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

STUB1-mediated ubiquitination regulates Fli-1 stability and CD4⁺T cell activation during inflammation.

Molecular medicine (Cambridge, Mass.)·2026

Same author

Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis.

Nature reviews. Rheumatology·2026

Same author

Endothelial <i>GATA6</i> deficiency suppresses intracellular TLR3-interferon signaling in HPAECs and promotes interferon response in HPASMCs.

bioRxiv : the preprint server for biology·2025

Same author

Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways.

Journal of scleroderma and related disorders·2025

Same author

Publisher Correction: An international perspective on the future of systemic sclerosis research.

Nature reviews. Rheumatology·2025

Same author

An international perspective on the future of systemic sclerosis research.

Nature reviews. Rheumatology·2025

Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026

Same journal

Foreword.

Rheumatic diseases clinics of North America·2026

Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026

Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026

Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026

Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026

See all related articles

This review explores the mechanisms of fibrosis in systemic sclerosis, a condition causing tissue hardening. It discusses new findings and potential targeted treatments for antifibrotic therapies.

Area of Science:

Rheumatology
Immunology
Pathophysiology

Background:

Systemic sclerosis is characterized by widespread organ fibrosis.
Understanding the underlying mechanisms of fibrosis is crucial for effective treatment.

Purpose of the Study:

To review the current understanding of systemic sclerosis pathophysiology.
To highlight recent discoveries and emerging research in fibrosis.
To identify opportunities for targeted antifibrotic therapies.

Main Methods:

Literature review of current research on systemic sclerosis fibrosis.
Analysis of recent discoveries and insights into fibrotic processes.
Identification of potential therapeutic targets.

Related Experiment Videos

Main Results:

Recent advances have shed light on key pathways driving fibrosis in systemic sclerosis.
Emerging research points to novel molecular targets for intervention.
Several potential strategies for targeted antifibrotic therapies are discussed.

Conclusions:

A deeper understanding of systemic sclerosis pathophysiology is evolving.
Targeted antifibrotic therapies hold promise for future treatment of systemic sclerosis.